Clinical Practice Guidelines and Recommendations
A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has recently released the new cholesterol treatment guideline. This update was based on a systematic review of the evidence and replaces the previous guidelines from 2002 that were widely accepted and implemented in clinical practice. The new cholesterol treatment guideline emphasizes matching the intensity of statin treatment to the level of atherosclerotic cardiovascular disease (ASCVD) risk and replaces the old paradigm of pursuing low-density lipoprotein cholesterol targets.New American Heart Association/American College of Cardiology Guidelines on Cardiovascular Risk: When Will Fitness Get the Recognition It Deserves?
During the American Heart Association (AHA) Scientific Sessions in November 2013, the AHA and the American College of Cardiology (ACC) jointly released new guidelines for the prevention and treatment of coronary artery disease (CAD). The guidelines focused on the assessment of cardiovascular risk1 and the treatment of blood lipids2 and received a great deal of attention from both the media and professional journals. These organizations are among the most experienced and qualified to develop guidelines, and their guidelines and scientific statements set the standard for clinical practice.
